ID   M3K3_HUMAN              Reviewed;         626 AA.
AC   Q99759; B2RCW2; Q5BKZ6; Q8N3I9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   05-OCT-2010, entry version 115.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 3;
DE            EC=2.7.11.25;
DE   AltName: Full=MAPK/ERK kinase kinase 3;
DE            Short=MEK kinase 3;
DE            Short=MEKK 3;
GN   Name=MAP3K3; Synonyms=MAPKKK3, MEKK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   MEDLINE=97160568; PubMed=9006902; DOI=10.1074/jbc.272.5.2668;
RA   Ellinger-Ziegelbauer H.C., Brown K., Kelly K., Siebenlist U.;
RT   "Direct activation of the stress-activated protein kinase (SAPK) and
RT   extracellular signal-regulated protein kinase (ERK) pathways by an
RT   inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK)
RT   derivative.";
RL   J. Biol. Chem. 272:2668-2674(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH MAP2K5.
RX   PubMed=12912994; DOI=10.1074/jbc.C300313200;
RA   Nakamura K., Johnson G.L.;
RT   "PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for
RT   activation of the ERK5 pathway.";
RL   J. Biol. Chem. 278:36989-36992(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH TRAF6.
RX   PubMed=14661019; DOI=10.1038/ni1014;
RA   Huang Q., Yang J., Lin Y., Walker C., Cheng J., Liu Z.G., Su B.;
RT   "Differential regulation of interleukin 1 receptor and Toll-like
RT   receptor signaling by MEKK3.";
RL   Nat. Immunol. 5:98-103(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH TRAF7.
RX   PubMed=14743216; DOI=10.1038/ncb1086;
RA   Bouwmeester T., Bauch A., Ruffner H., Angrand P.-O., Bergamini G.,
RA   Croughton K., Cruciat C., Eberhard D., Gagneur J., Ghidelli S.,
RA   Hopf C., Huhse B., Mangano R., Michon A.-M., Schirle M., Schlegl J.,
RA   Schwab M., Stein M.A., Bauer A., Casari G., Drewes G., Gavin A.-C.,
RA   Jackson D.B., Joberty G., Neubauer G., Rick J., Kuster B.,
RA   Superti-Furga G.;
RT   "A physical and functional map of the human TNF-alpha/NF-kappa B
RT   signal transduction pathway.";
RL   Nat. Cell Biol. 6:97-105(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-288; SER-289 AND
RP   THR-294, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-166; SER-234;
RP   SER-237; SER-250; SER-337; SER-340 AND SER-355, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; SER-130; SER-145;
RP   SER-147; SER-166; SER-168; SER-175; SER-176; SER-237; SER-250;
RP   SER-311; SER-314; SER-316; THR-317; SER-337; SER-340; THR-353;
RP   SER-355; SER-464 AND SER-526, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337 AND SER-340, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-281.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3
CC       transcriptional regulators.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-530 (By
CC       similarity).
CC   -!- SUBUNIT: Binds both upstream activators and downstream substrates
CC       in multimolecular complexes. Part of a complex with MAP2K3, RAC1
CC       and CCM2. Interacts with MAP2K5 and SPAG9.
CC   -!- INTERACTION:
CC       Q6Q0C0:TRAF7; NbExp=2; IntAct=EBI-307281, EBI-307556;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99759-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99759-2; Sequence=VSP_035967;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 OPR domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U78876; AAB41729.1; -; mRNA.
DR   EMBL; AK315305; BAG37709.1; -; mRNA.
DR   EMBL; AL834303; CAD38973.1; -; mRNA.
DR   EMBL; AC046185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94297.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94298.1; -; Genomic_DNA.
DR   EMBL; BC090859; AAH90859.1; -; mRNA.
DR   EMBL; BC093672; AAH93672.1; -; mRNA.
DR   EMBL; BC093674; AAH93674.1; -; mRNA.
DR   IPI; IPI00017801; -.
DR   IPI; IPI00181703; -.
DR   RefSeq; NP_002392.2; -.
DR   RefSeq; NP_976226.1; -.
DR   UniGene; Hs.29282; -.
DR   PDB; 2C60; X-ray; 1.25 A; A=37-124.
DR   PDB; 2JRH; NMR; -; A=42-126.
DR   PDB; 2O2V; X-ray; 1.83 A; B=37-124.
DR   PDB; 2PPH; NMR; -; A=42-126.
DR   PDBsum; 2C60; -.
DR   PDBsum; 2JRH; -.
DR   PDBsum; 2O2V; -.
DR   PDBsum; 2PPH; -.
DR   ProteinModelPortal; Q99759; -.
DR   SMR; Q99759; 361-622.
DR   DIP; DIP-27521N; -.
DR   IntAct; Q99759; 171.
DR   MINT; MINT-272157; -.
DR   STRING; Q99759; -.
DR   PhosphoSite; Q99759; -.
DR   PRIDE; Q99759; -.
DR   Ensembl; ENST00000361733; ENSP00000354485; ENSG00000198909.
DR   GeneID; 4215; -.
DR   KEGG; hsa:4215; -.
DR   NMPDR; fig|9606.3.peg.14206; -.
DR   UCSC; uc002jbg.1; human.
DR   CTD; 4215; -.
DR   GeneCards; GC17P061699; -.
DR   HGNC; HGNC:6855; MAP3K3.
DR   HPA; CAB007764; -.
DR   MIM; 602539; gene.
DR   PharmGKB; PA30599; -.
DR   eggNOG; prNOG06004; -.
DR   HOVERGEN; HBG006303; -.
DR   OMA; IRSVTGT; -.
DR   BRENDA; 2.7.11.25; 247.
DR   BRENDA; 2.7.12.2; 247.
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 16621; -.
DR   ArrayExpress; Q99759; -.
DR   Bgee; Q99759; -.
DR   CleanEx; HS_MAP3K3; -.
DR   Genevestigator; Q99759; -.
DR   GermOnline; ENSG00000198909; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0000165; P:MAPKKK cascade; TAS:ProtInc.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-k...; IEP:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:MGI.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015748; MAPKKK3.
DR   InterPro; IPR000270; OPR_PB1.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22986:SF64; MAPKKK3; 1.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    626       Mitogen-activated protein kinase kinase
FT                                kinase 3.
FT                                /FTId=PRO_0000086245.
FT   DOMAIN       44    123       OPR.
FT   DOMAIN      362    622       Protein kinase.
FT   NP_BIND     368    376       ATP (By similarity).
FT   ACT_SITE    489    489       Proton acceptor (By similarity).
FT   BINDING     391    391       ATP (By similarity).
FT   MOD_RES     129    129       Phosphoserine.
FT   MOD_RES     130    130       Phosphoserine.
FT   MOD_RES     131    131       Phosphoserine.
FT   MOD_RES     145    145       Phosphoserine.
FT   MOD_RES     147    147       Phosphoserine.
FT   MOD_RES     166    166       Phosphoserine.
FT   MOD_RES     168    168       Phosphoserine.
FT   MOD_RES     175    175       Phosphoserine.
FT   MOD_RES     176    176       Phosphoserine.
FT   MOD_RES     234    234       Phosphoserine.
FT   MOD_RES     237    237       Phosphoserine.
FT   MOD_RES     250    250       Phosphoserine.
FT   MOD_RES     288    288       Phosphotyrosine.
FT   MOD_RES     289    289       Phosphoserine.
FT   MOD_RES     294    294       Phosphothreonine.
FT   MOD_RES     311    311       Phosphoserine.
FT   MOD_RES     314    314       Phosphoserine.
FT   MOD_RES     316    316       Phosphoserine.
FT   MOD_RES     317    317       Phosphothreonine.
FT   MOD_RES     337    337       Phosphoserine.
FT   MOD_RES     340    340       Phosphoserine.
FT   MOD_RES     353    353       Phosphothreonine.
FT   MOD_RES     355    355       Phosphoserine.
FT   MOD_RES     464    464       Phosphoserine.
FT   MOD_RES     526    526       Phosphoserine.
FT   MOD_RES     530    530       Phosphothreonine (By similarity).
FT   VAR_SEQ      42     42       Q -> QKKHNSSSSALLNSPTVTTSSCAGASEKKKFL (in
FT                                isoform 2).
FT                                /FTId=VSP_035967.
FT   VARIANT     281    281       V -> M (in dbSNP:rs36109904).
FT                                /FTId=VAR_040685.
FT   VARIANT     325    325       A -> G (in dbSNP:rs34042309).
FT                                /FTId=VAR_037275.
FT   VARIANT     435    435       A -> G (in dbSNP:rs9910858).
FT                                /FTId=VAR_037276.
FT   CONFLICT    135    135       G -> E (in Ref. 1; AAB41729).
FT   STRAND       45     51
FT   STRAND       54     60
FT   HELIX        66     77
FT   STRAND       82     86
FT   STRAND       91     93
FT   HELIX        97    109
FT   STRAND      115    121
SQ   SEQUENCE   626 AA;  70898 MW;  28129168A57571DD CRC64;
     MDEQEALNSI MNDLVALQMN RRHRMPGYET MKNKDTGHSN RQSDVRIKFE HNGERRIIAF
     SRPVKYEDVE HKVTTVFGQP LDLHYMNNEL SILLKNQDDL DKAIDILDRS SSMKSLRILL
     LSQDRNHNSS SPHSGVSRQV RIKASQSAGD INTIYQPPEP RSRHLSVSSQ NPGRSSPPPG
     YVPERQQHIA RQGSYTSINS EGEFIPETSE QCMLDPLSSA ENSLSGSCQS LDRSADSPSF
     RKSRMSRAQS FPDNRQEYSD RETQLYDKGV KGGTYPRRYH VSVHHKDYSD GRRTFPRIRR
     HQGNLFTLVP SSRSLSTNGE NMGLAVQYLD PRGRLRSADS ENALSVQERN VPTKSPSAPI
     NWRRGKLLGQ GAFGRVYLCY DVDTGRELAS KQVQFDPDSP ETSKEVSALE CEIQLLKNLQ
     HERIVQYYGC LRDRAEKTLT IFMEYMPGGS VKDQLKAYGA LTESVTRKYT RQILEGMSYL
     HSNMIVHRDI KGANILRDSA GNVKLGDFGA SKRLQTICMS GTGMRSVTGT PYWMSPEVIS
     GEGYGRKADV WSLGCTVVEM LTEKPPWAEY EAMAAIFKIA TQPTNPQLPS HISEHGRDFL
     RRIFVEARQR PSAEELLTHH FAQLMY
//
